Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature
- PMID: 11244446
- DOI: 10.1038/sj.bmt.1702738
Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature
Abstract
Congenital erythropoietic porphyria (CEP) is a rare autosomal recessive disorder of porphyrin metabolism in which the genetic defect is the deficiency of uroporphyrinogen III cosynthase (UIIIC). Deficiency of this enzyme results in an accumulation of high amounts of uroporphyrin I in all tissues leading to hemolytic anemia, splenomegaly, erythrodontia, bone fragility, exquisite photosensitivity and mutilating skin lesions. We describe the case of a 23-month-old boy who was cured of his CEP by a matched-sibling allogeneic bone marrow transplant, and review the published clinical experience regarding transplantation in this disease. He is alive and disease-free 15 months post transplant. All of his disease manifestations except for the erythrodontia have resolved. His UIIIC level and stool and erythrocyte porphyrin metabolites have almost completely corrected. He is the sixth child reported to be cured of this disease by stem cell transplantation, five cases being long-term survivors. If patients with this disease have an HLA-matched sibling, then stem cell transplantation should be strongly considered because this is currently the only known curative therapy.
Similar articles
-
Bullous skin lesions in a jaundiced infant after phototherapy: a case of congenital erythropoietic porphyria.Turk J Pediatr. 2013 Mar-Apr;55(2):218-21. Turk J Pediatr. 2013. PMID: 24192686
-
Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease).Bone Marrow Transplant. 1996 Jul;18(1):217-20. Bone Marrow Transplant. 1996. PMID: 8832020
-
Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.Pediatr Dermatol. 2013 Jul-Aug;30(4):484-9. doi: 10.1111/pde.12117. Epub 2013 Apr 5. Pediatr Dermatol. 2013. PMID: 23557135
-
Molecular genetics of congenital erythropoietic porphyria.Semin Liver Dis. 1998;18(1):77-84. doi: 10.1055/s-2007-1007143. Semin Liver Dis. 1998. PMID: 9516681 Review.
-
Congenital erythropoietic porphyria.J Am Acad Dermatol. 1997 Apr;36(4):594-610. doi: 10.1016/s0190-9622(97)70249-4. J Am Acad Dermatol. 1997. PMID: 9092747 Review.
Cited by
-
Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria.Mol Biol Rep. 2012 Jun;39(6):6731-5. doi: 10.1007/s11033-012-1497-z. Epub 2012 Feb 18. Mol Biol Rep. 2012. PMID: 22350154
-
Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.Am J Hum Genet. 2012 Jul 13;91(1):109-21. doi: 10.1016/j.ajhg.2012.05.026. Am J Hum Genet. 2012. PMID: 22795135 Free PMC article.
-
Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation in an adult: A case report.Skin Health Dis. 2024 Jan 27;4(2):e342. doi: 10.1002/ski2.342. eCollection 2024 Apr. Skin Health Dis. 2024. PMID: 38577034 Free PMC article.
-
Very Early Diagnosis and Management of Congenital Erythropoietic Porphyria.Clin Pediatr (Phila). 2023 Jun;62(5):399-403. doi: 10.1177/00099228221128661. Epub 2022 Oct 11. Clin Pediatr (Phila). 2023. PMID: 36217751 Free PMC article.
-
Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.Am J Hum Genet. 2006 Apr;78(4):645-58. doi: 10.1086/502667. Epub 2006 Feb 9. Am J Hum Genet. 2006. PMID: 16532394 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials